Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease

Charles H Pegelow1, Eric A Macklin, Franklin G Moser

  • 1Department of Pediatrics, University of Miami, Miami, FL 33101, USA. cpegelow@miami.edu

Blood
|April 4, 2002
PubMed

Insights

Silent cerebral infarcts are common in children with sickle cell anemia (HbSS), increasing stroke risk. Further research is needed to determine optimal preventive strategies for these silent brain injuries.

Area of Science:

  • Pediatric Neurology
  • Hematology
  • Neuroimaging

Background:

  • Children with sickle cell anemia (HbSS) face high risks of overt stroke and silent cerebral infarcts.
  • Silent infarcts are linked to neuropsychometric deficits in affected children.

Purpose of the Study:

  • To investigate the prevalence, localization, recurrence, and progression of silent cerebral infarcts in children with HbSS.
  • To compare characteristics of silent infarcts with stroke-associated infarcts.

Main Methods:

  • Analysis of magnetic resonance imaging (MRI) histories from 266 children with HbSS (aged 6-19) in the Cooperative Study of Sickle Cell Disease (CSSCD).
  • Examination of infarct prevalence, localization, and association with sex and age.
  • Assessment of incidence of new stroke and silent infarct progression in relation to baseline infarct status.

Main Results:

  • Baseline prevalence of silent infarcts was 21.8%, higher than previously reported due to improved MRI technology.
  • Silent infarcts were smaller and less frequently located in the frontal/parietal cortex compared to stroke-associated infarcts.
  • Children with silent infarcts showed increased incidence of new stroke and silent infarct progression.

Conclusions:

  • Silent cerebral infarcts are a significant finding in pediatric HbSS, associated with increased risk of future neurological events.
  • Current data suggest MRI is best reserved for symptomatic children or those with specific risk factors.
  • Further studies are needed to establish the risk-benefit of chronic transfusion for silent infarcts in children with normal cerebral arterial velocities.